Company Filing History:
Years Active: 2015-2016
Title: Luc Oullet: Innovator in Macrocyclic Compounds
Introduction
Luc Oullet is a notable inventor based in Sherbrooke, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of macrocyclic compounds. His work focuses on creating novel compounds that can be used in various medical applications.
Latest Patents
Luc Oullet holds 2 patents that showcase his innovative approach to drug development. His latest patents include "Macrocyclic ghrelin receptor modulators and methods of using the same." This invention provides novel conformationally-defined macrocyclic compounds that function as selective modulators of the ghrelin receptor. These compounds are useful as agonists for treating a range of medical conditions, including metabolic disorders, cardiovascular issues, and obesity. Another patent involves "Intermediates for macrocyclic compounds," which focuses on novel macrocyclic compounds that are antagonists of the motilin receptor, useful in treating motility dysfunction.
Career Highlights
Luc Oullet is currently associated with Ocera Therapeutics, Inc., where he continues to advance his research in pharmacology. His work has the potential to impact various therapeutic areas significantly.
Collaborations
Some of his notable coworkers include Hamid R Hoveyda and Kamel Benakli, who have collaborated with him on various projects.
Conclusion
Luc Oullet's contributions to the field of medicinal chemistry through his innovative patents highlight his role as a key inventor in developing new therapeutic agents. His work continues to pave the way for advancements in treating complex medical conditions.